Vimarsana
Biggest News Aggregation in the World

Page 12 - Comparative Effectiveness News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Comparative Effectiveness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Comparative Effectiveness Today - Breaking & Trending Today

Panel Recommends Energy-Based Devices as Treatment of Acne Scars - Vimarsana News

Panel Recommends Energy-Based Devices as Treatment of Acne Scars

Panel suggests that laser resurfacing does not have to be delayed at least 6 months post isotretinoin in acne patients.

Evaluating comparative effectiveness of Pfizer-BioNtech and Moderna vaccines among US veterans - Vimarsana News

Evaluating comparative effectiveness of Pfizer-BioNtech and Moderna vaccines among US veterans

A new study provided evidence of a lower 24-week risk of COVID-19–related outcomes among recipients of the mRNA-1273 vaccine, compared to their counterparts who received the BNT162b2 vaccine.

FDA Panel Backs First Pill for COVID-19 by a Small Margin - Vimarsana News

FDA Panel Backs First Pill for COVID-19 by a Small Margin

Although some panel members backed the drug for emergency use, there were still a lot of concerns because of a lack of safety and efficacy data.

Clinical trials begin for COVID-19 oral therapeutics discovered using LSU-developed AI - Vimarsana News

Clinical trials begin for COVID-19 oral therapeutics discovered using LSU-developed AI

BATON ROUGE, La. – Skymount Medical has partnered with Riverside University Health System, or RUHS, Medical Center to conduct the first U.S. clinical trial on the efficacy of COVID-19 oral

Source: ktbs.com
Clinical trials begin for COVID-19 oral therapeutics discovered using LSU-developed AI - Vimarsana News

Clinical trials begin for COVID-19 oral therapeutics discovered using LSU-developed AI

According to a Friday morning news release from Louisiana State University (LSU), Skymount Medical has partnered with Riverside University Health System, or RUHS, Medical Center to conduct the first U.S. clinical trial on the efficacy of COVID-19 oral therapeutics discovered by LSU researchers using artificial intelligence, or AI.

Source: wbrz.com